Skip to main content
Signal8
BERMAN ROBERT ANDREW profile photo

Robert Andrew Berman

CIK: 0001258360

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

enVVeno Medical Corp logo
NVNO

enVVeno Medical Corp

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • enVVeno Medical Corp logo
    NVNO

    enVVeno Medical Corp

    Dec 16, 2025
    Other(J)

    Restricted Stock Units

    Direct
    200K shares-
  • enVVeno Medical Corp logo
    NVNO

    enVVeno Medical Corp

    Dec 19, 2024
    Purchase(P)
    Direct
    12K shares at avg. $2.55$31K
  • enVVeno Medical Corp logo
    NVNO

    enVVeno Medical Corp

    Dec 18, 2024
    Award(A)

    Stock Options

    Direct
    200K shares-

1-3 of 3

About BERMAN ROBERT ANDREW

BERMAN ROBERT ANDREW (SEC CIK 0001258360) files insider reports with the SEC as Chief Executive Officer of enVVeno Medical Corp (NVNO).

Signal8 holds 3 ownership filings by BERMAN ROBERT ANDREW, all Form 4s, filed between Dec 19, 2024 and Dec 18, 2025. Those filings report 3 transactions, from Dec 18, 2024 to Dec 16, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on BERMAN ROBERT ANDREW's filings is in IRVINE, CA.

Recent filings by BERMAN ROBERT ANDREW

  • Dec 16, 2025: Other transaction of NVNO derivative securities (Form 4, code J).
  • Dec 19, 2024: Open-market purchase of NVNO shares (Form 4, code P).
  • Dec 18, 2024: Grant or award of NVNO derivative securities (Form 4, code A).

Other insiders filing for enVVeno Medical Corp (NVNO)

How to read Form 4 transaction codes